By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    stress disorder
    5 Ways To Manage Post-Traumatic Stress Disorder
    October 27, 2021
    Medical device classification and development strategies
    Medical device classification and development strategies
    April 5, 2023
    varicose veins
    Varicose Veins Prevention: 3 Lifestyle Changes to Make Right Now
    May 1, 2022
    Latest News
    4 Signs It’s Time to See a Therapist
    May 24, 2023
    11 Ways To Modernize Your Private Practice
    May 17, 2023
    How to Recognize the Signs of Hormonal Imbalance in Men
    May 29, 2023
    Important Steps to Take for Scaling A Biopharma Product
    May 2, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Big Things Are On The Horizon For Blockchain In Healthcare
    March 9, 2022
    MACRA: a rule worth learning
    December 12, 2017
    Stop Worrying About Your Lifespan – Your Healthspan Really Matters
    October 14, 2019
    Latest News
    MRI Sedation Options: What You Should Know Before Screening
    May 17, 2023
    What is the Process of Creating Medicine from Nature?
    May 2, 2023
    Choosing the Right Treatment Option for Varicose Veins
    May 2, 2023
    What Are Wrong-Site Surgeries and How Do They Occur?
    April 27, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Unintended Consequences of Changing the Current 510K System for “Moderate Risk” Devices
Share
Sign In
Notification Show More
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Unintended Consequences of Changing the Current 510K System for “Moderate Risk” Devices
BusinessMedical Devices

Unintended Consequences of Changing the Current 510K System for “Moderate Risk” Devices

DavidEWilliams
Last updated: 2011/08/06 at 7:57 AM
DavidEWilliams
Share
6 Min Read
SHARE

 

 

On July 29 an expert panel assembled by the Institute of Medicine found that the current regulatory framework for “substantially equivalent” devices (known as the FDA 510K process) was flawed and called for it to be replaced with a system better designed to protect the public’s health.  The findings have some merit, but the recommendations have the potential to substantially decrease innovation at a time when more, rather than less, innovation is required to increase the quality and reduce the cost of health care in the US.

It should be noted that the current 510K system is for “moderate risk” devices only.  The creation of an artificial kidney, for instance, would be viewed as a “high risk” device. and would be required to undergo exhaustive human clinical trials to be granted approval by the FDA.  An endoscope with a better optical camera enabling it to find more anomalies during an endoscopic procedure is considered “moderate risk” and  requires that the manufacturer show that the device is “substantially equivalent” to existing products in the market.

More Read

get a career in medical device sales

What Are the Benefits of Attending Medical Sales College?

Subscription Management Solutions Are Crucial for Telemedicine
Comfort And Safety: 7 Ways Healthcare Organizations Can Create A Better Environment For Their Patients
Best Practices for Healthcare Call Centers Should Follow in 2023
How Hospitals and Other Healthcare Providers Can Boost Employee Morale

But the process doesn’t stop there.  Companies are required to follow very detailed processes once a product is approved to show that their product is compliant with FDA regulations.  These processes require a company to register all customer complaints and show that they have a process for dealing with them.  Additionally, any claims of injury of a patient by the device need to be immediately brought to the attention of the FDA.  There is a final “stick” used by the FDA that makes willful acts of omission about the safety of a device a criminal penalty, with the CEO of the company being personally liable.

Further, good physicians don’t just gravitate to new products unless there is a substantial body of evidence to show the product has clinical utility.  This comes from clinical trials by the physician community.  While some notable companies have abused this practice by paying physicians to promote their products, this is the exception, not the rule.  Recent disclosure practices, required by professional societies and academic institutions, are working to root out the problem.  This practice, however, is independent of what process the device goes through to obtain approval.

The biggest unintended consequence of overhauling the current 510K process is its effect on investment in the industry.  Investment firms (and investment committees in large corporations) usually look at four types of risk –market, technical, regulatory and reimbursement– before deciding to make investments.  Obviously, the first two are independent of regulatory requirements.  The last two, however, are actually related.

A new device that is required to go through full clinical trials (known as a “PMA”) can often require $50 million to $100 million in investment to bring it to market and significantly more to become profitable.  A device deemed substantially equivalent and utilizing the 510K process requires approximately half that amount.  Note that the difference isn’t the amount spent on determining the safety of the device, but rather the huge cost of carrying a non-income producing staff while the studies are completed.

Obviously, while there are still investments being made in companies requiring $100 million to get to market, these are becoming less common.  In fact, many of the venture capital firms that focused on medical device investing exclusively have either gone out of business or shifted their investment strategy to other markets.  This has been driven, in large part, by the difficult reimbursement environment, which appears to be driving down reimbursement with each passing day.  If an investor doesn’t have the high likelihood of making a reasonable rate of return after nearly a decade of investment, they will look for other places to invest.

While economics should never be a good justification to enable devices that are unsafe to enter the market, the current 510K process is designed to be used for moderate risk devices and carries with it considerable penalties (financial and criminal) to minimize the likelihood of such risk.  Furthermore, these devices are being used by physicians who aren’t going to take safety risks with an unproven product.  Physicians will buy these devices for research studies initially, until they see a body of evidence that convinces them of the merit (and lack of harm) of these devices.

Rather than throw the baby out with the bath water, the Committee should contemplate some “tweaks” to the existing system that might improve safety.  I’ll suggest some potential improvements to the current system in my next blog post.

This is a guest post from Rick Lifsitz, a colleague of mine from MedPharma Partners and a serial entrepreneur .

 

 


TAGGED: FDA, healthcare business, medical devices

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
DavidEWilliams August 6, 2011
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article OTC Drugs Should Qualify as Medical Expense for Tax Purposes
Next Article Massachusetts Hospitals Gain Under ObamaCare

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

brush your day
How Many Times A Day Should You Brush Your Teeth?
Dental health May 29, 2023
Chiropractic Laser Therapy: A Beacon of Hope for Chronic Pain Sufferers
Chiropractic Laser Therapy: A Beacon of Hope for Chronic Pain Sufferers
Therapies May 29, 2023
nursing trends and predictions
Biggest Nursing Trends and Predictions for 2023
Nursing May 25, 2023
medical answering service
How Medical Answering Services Can Improve Patient Care
Technology May 25, 2023

You Might also Like

medical devices
Technology

Post Market Surveillance for Medical Devices: Essential or Overreaching?

May 11, 2023
scaling a pharmaceutical product
HealthMedicare

Important Steps to Take for Scaling A Biopharma Product

May 2, 2023
Types of Remote Access Solutions for Hospitals
Medicare

Types of Remote Access Solutions for Hospitals

April 27, 2023
FDA approved health supplements
Health

How Do You Make Sure That a Supplement Is FDA Approved?

April 25, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?